1. Quality of Life (QoL) in Non-Acute Vogt-Koyanagi-Harada Disease (VKHD) at Two Time Points 24 Months Apart.
- Author
-
Souto FMS, Missaka RFBG, Lavezzo MM, Nóbrega PFC, Sakata VM, Oyamada MK, Hirata CE, and Yamamoto JH
- Subjects
- Humans, Male, Female, Adult, Surveys and Questionnaires, Middle Aged, Follow-Up Studies, Sickness Impact Profile, Contrast Sensitivity physiology, Time Factors, Young Adult, Prospective Studies, Quality of Life, Uveomeningoencephalitic Syndrome drug therapy, Uveomeningoencephalitic Syndrome physiopathology, Uveomeningoencephalitic Syndrome diagnosis, Visual Acuity physiology
- Abstract
Aims: To investigate the changes in quality-of-life (QoL) metrics at a 24-month interval in non-acute VKHD patients and their association with inflammation, treatment, and visual function., Methods: SF-36 and VFQ-25 questionnaires were administered at two 24-month-apart moments to 22 non-acute VKHD patients followed for ≥12 months since acute disease onset. "Improvement," "unchanged," or "worsening" in questionnaires scores (difference >5-point) between M1 and M2 and their associations were sought., Results: Absence of systemic treatment or optic disc hyperfluorescence was associated with improved general health (SF-36). Improvement in binocular contrast sensitivity resulted in better ocular pain score; absence of anterior uveitis relapse, stable fundus findings, no use of cyclosporine or no intravitreal injections resulted in unchanged/better dependency score; no intravitreal injections resulted in unchanged/better mental health score (VFQ-25)., Conclusion: Stability/improvement in QoL scores was associated with controlled inflammation, better visual function, and no need for treatment. Subclinical inflammatory signs did not impact QoL scores.
- Published
- 2024
- Full Text
- View/download PDF